S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
NASDAQ:GCTK

GlucoTrack (GCTK) Stock Price, News & Analysis

$0.72
+0.19 (+36.19%)
(As of 04/17/2024 ET)
Today's Range
$0.50
$0.72
50-Day Range
$0.21
$0.72
52-Week Range
$0.13
$1.00
Volume
636,968 shs
Average Volume
204,480 shs
Market Capitalization
$19.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GCTK stock logo

About GlucoTrack Stock (NASDAQ:GCTK)

GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

GCTK Stock Price History

GCTK Stock News Headlines

GlucoTrack, Inc. (GCTK)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
UK mortgage arrears rise 50% amid high interest rates
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Glucotrack names Luis Malavé board chair
GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE
GLUCOTRACK ANNOUNCES NEW VP OF MARKETING
See More Headlines
Receive GCTK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GlucoTrack and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/28/2024
Today
4/17/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:GCTK
Employees
6
Year Founded
N/A

Profitability

Net Income
$-7,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.15 per share

Miscellaneous

Free Float
22,020,000
Market Cap
$19.13 million
Optionable
Not Optionable
Beta
0.29
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Paul V. Goode Ph.D. (Age 55)
    Chief Executive Officer
    Comp: $225k
  • Mr. Mark Tapsak Ph.D. (Age 55)
    Vice President of Technology
    Comp: $165k
  • Ms. Drinda Benjamin (Age 48)
    Vice President of Marketing
  • Mr. James P. Thrower Ph.D. (Age 54)
    Vice President of Engineering
    Comp: $230k
  • Mr. Avner Gal MBA (Age 70)
    MSc.EE, Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board
    Comp: $187.39k
  • Mr. David Malka BA (Age 59)
    Co-Founder
    Comp: $191.86k
  • Mr. James S. Cardwell (Age 63)
    Chief Financial Officer

GCTK Stock Analysis - Frequently Asked Questions

How have GCTK shares performed in 2024?

GlucoTrack's stock was trading at $0.2615 at the beginning of the year. Since then, GCTK shares have increased by 173.4% and is now trading at $0.7150.
View the best growth stocks for 2024 here
.

Are investors shorting GlucoTrack?

GlucoTrack saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 98,100 shares, an increase of 1,157.7% from the March 15th total of 7,800 shares. Based on an average trading volume of 110,700 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.5% of the shares of the stock are short sold.
View GlucoTrack's Short Interest
.

When is GlucoTrack's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our GCTK earnings forecast
.

How were GlucoTrack's earnings last quarter?

GlucoTrack, Inc. (NASDAQ:GCTK) released its earnings results on Thursday, March, 28th. The company reported ($0.10) earnings per share for the quarter.

How do I buy shares of GlucoTrack?

Shares of GCTK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GCTK) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners